Melatonin vs. dexmedetomidine for sleep induction in children before electroencephalography
Abstract
Background and objectives: In children requiring electroencephalography (EEG), sleep recording can provide crucial information.As EEG recordings during spontaneous sleep are not always possible, pharmacological sleepinducing agents are sometimes required.The aim of the study was to evaluate safety and efficacy of melatonin (Mel) and dexmedetomidine (Dex; intranasal and sublingual application) for sleep induction prior to EEG.Methods: In this prospective randomized study, 156 consecutive patients aged 1-19 years were enrolled and randomized by draw into melatonin group (Mel; n = 54; dose: 0.1 mg/kg), dexmedetomidine (Dex) sublingual group (DexL; n = 51; dose: 3 mcg/kg) or dexmedetomidine intranasal group (DexN; n = 51; dose: 3 mcg/kg).We compared the groups in several parameters regarding efficacy and safety and also carried out a separate analysis for a subgroup of patients with complex behavioral problems.Results: Sleep was achieved in 93.6% of participants after the first application of the drug and in 99.4% after the application of another if needed.Mel was effective as the first drug in 83.3% and Dex in 99.0% ( p < 0.001); in the subgroup of patients with complex developmental problems Mel was effective in 73.4% and Dex in 100% ( p < 0.001).The patients fell asleep faster after intranasal application of Dex than after sublingual application ( p = 0.006).None of the patients had respiratory depression, bradycardia, desaturation, or hypotension.Conclusions: Mel and Dex are…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 156 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.